Clinical Outcomes of Pars Plana Vitrectomy and Polytetrafluoroethylene (Gore-Tex) Scleral Fixation of a Monofocal Aspheric Intraocular Lens (Akreos AO60).

IF 0.5 Q4 OPHTHALMOLOGY Journal of VitreoRetinal Diseases Pub Date : 2024-08-02 eCollection Date: 2024-09-01 DOI:10.1177/24741264241260094
Amit V Mishra, Rosanna Martens, Graeme K Loh, Rizwan Somani, Mark D J Greve, Mark E Seamone
{"title":"Clinical Outcomes of Pars Plana Vitrectomy and Polytetrafluoroethylene (Gore-Tex) Scleral Fixation of a Monofocal Aspheric Intraocular Lens (Akreos AO60).","authors":"Amit V Mishra, Rosanna Martens, Graeme K Loh, Rizwan Somani, Mark D J Greve, Mark E Seamone","doi":"10.1177/24741264241260094","DOIUrl":null,"url":null,"abstract":"<p><p><b>Purpose:</b> To evaluate the visual outcomes and complications with a polytetrafluoroethylene (Gore-Tex)-fixated intraocular lens (IOL) (Akreos AO60, Bausch + Lomb). <b>Methods:</b> Eyes with inadequate capsule support for in-the-bag IOL implantation had pars plana vitrectomy (PPV) and IOL placement at a single center. The main outcome measures were the postoperative visual acuity (VA) and complication rates. <b>Results:</b> During the study, 783 surgeries were performed. The mean visual acuity gain was 28.5 Early Treatment Diabetic Retinopathy Study letters (<i>P</i> < .01), with a mean time to best VA of 3.05 months. Statistical hypotony (intraocular pressure <6.5 mm Hg) was present in 214 cases (27.3%), and clinical features of hypotony were present in 46 cases. Five percent of the complications were directly related to the IOL. There were 3 cases of IOL opacification, 2 with silicone oil endotamponade and 1 with perfluoropropane endotamponade. <b>Conclusions:</b> PPV with Akreos IOL implantation was an effective technique for secondary IOL placement. Complications directly related to the IOL were uncommon.</p>","PeriodicalId":17919,"journal":{"name":"Journal of VitreoRetinal Diseases","volume":null,"pages":null},"PeriodicalIF":0.5000,"publicationDate":"2024-08-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11425783/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of VitreoRetinal Diseases","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1177/24741264241260094","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/9/1 0:00:00","PubModel":"eCollection","JCR":"Q4","JCRName":"OPHTHALMOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Purpose: To evaluate the visual outcomes and complications with a polytetrafluoroethylene (Gore-Tex)-fixated intraocular lens (IOL) (Akreos AO60, Bausch + Lomb). Methods: Eyes with inadequate capsule support for in-the-bag IOL implantation had pars plana vitrectomy (PPV) and IOL placement at a single center. The main outcome measures were the postoperative visual acuity (VA) and complication rates. Results: During the study, 783 surgeries were performed. The mean visual acuity gain was 28.5 Early Treatment Diabetic Retinopathy Study letters (P < .01), with a mean time to best VA of 3.05 months. Statistical hypotony (intraocular pressure <6.5 mm Hg) was present in 214 cases (27.3%), and clinical features of hypotony were present in 46 cases. Five percent of the complications were directly related to the IOL. There were 3 cases of IOL opacification, 2 with silicone oil endotamponade and 1 with perfluoropropane endotamponade. Conclusions: PPV with Akreos IOL implantation was an effective technique for secondary IOL placement. Complications directly related to the IOL were uncommon.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
玻璃体旁切除术和聚四氟乙烯(Gore-Tex)巩膜固定单焦点非球面眼内透镜(Akreos AO60)的临床效果。
目的:评估聚四氟乙烯(Gore-Tex)固定眼内人工晶体(Akreos AO60,博士伦公司)的视觉效果和并发症。方法:囊内人工晶体植入术囊内支持不足的眼球在一个中心进行了玻璃体旁切除术(PPV)和人工晶体植入术。主要结果指标为术后视力(VA)和并发症发生率。结果:研究期间共进行了 783 例手术。平均视力提高了 28.5 个早期治疗糖尿病视网膜病变研究字母(P < .01),达到最佳视力的平均时间为 3.05 个月。统计低眼压(眼内压结论:PPV与Akreos人工晶体植入术是一种有效的二次人工晶体植入技术。与人工晶体直接相关的并发症并不常见。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
1.20
自引率
16.70%
发文量
0
期刊最新文献
From the Editor-in-Chief. Update on Retinal Drug Safety: Proceedings of the ASRS ReST Committee Webinar Part 1. Extended Intraocular Drug-Delivery Platforms for the Treatment of Retinal and Choroidal Diseases. Successful Treatment of Central Retinal Artery Occlusion With Tissue Plasminogen Activator Followed by Recurrent Retinal Ischemia 2024 Distinguished Contributor Awards.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1